Malignant mesothelioma among US Medicare beneficiaries: incidence, prevalence and therapy, 2016-2019
Conclusions
Mesothelioma was a prevalent disease among FFS Medicare beneficiaries during 2016–2019, and a limited proportion of beneficiaries received all three therapy modalities. Medicare data build on findings from cancer registry data to enhance our understanding of the mesothelioma burden and therapy patterns.
Source: Occupational and Environmental Medicine - Category: Occupational Health Authors: Kurth, L., Mazurek, J. M., Blackley, D. J. Tags: Editor's choice Workplace Source Type: research
More News: Asbestosis | Cancer | Cancer & Oncology | Chemotherapy | Environmental Health | Medicare | Mesothelioma | Occupational Health | Study